GSTCD expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.126000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.557200E-01
Normal-vs-Stage2
6.923400E-01
Normal-vs-Stage3
1.789540E-02
Normal-vs-Stage4
7.164800E-01
Stage1-vs-Stage2
2.610800E-01
Stage1-vs-Stage3
3.097900E-02
Stage1-vs-Stage4
9.428400E-01
Stage2-vs-Stage3
1.575510E-04
Stage2-vs-Stage4
2.999200E-01
Stage3-vs-Stage4
8.657800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.371000E-01
Normal-vs-AfricanAmerican
9.354600E-01
Normal-vs-Asian
3.567600E-01
Caucasian-vs-AfricanAmerican
6.867400E-01
Caucasian-vs-Asian
2.412800E-01
AfricanAmerican-vs-Asian
2.331000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.541200E-01
Normal-vs-Female
9.504800E-01
Male-vs-Female
2.824600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.399400E-01
Normal-vs-Age(41-60Yrs)
8.776600E-01
Normal-vs-Age(61-80Yrs)
6.902800E-01
Normal-vs-Age(81-100Yrs)
7.568600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.247590E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.812600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.218400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.074400E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.586200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.556400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.603000E-01
Normal-vs-Daily Drinker
1.802360E-01
Normal-vs-Weekly Drinker
6.762200E-01
Normal-vs-Occasional Drinker
6.119000E-01
Normal-vs-Social Drinker
9.686800E-01
Non Drinker-vs-Daily Drinker
2.961400E-01
Non Drinker-vs-Weekly Drinker
8.202200E-01
Non Drinker-vs-Occasional Drinker
7.141900E-02
Non Drinker-vs-Social Drinker
2.271200E-01
Daily Drinker-vs-Weekly Drinker
3.907800E-01
Daily Drinker-vs-Occasional Drinker
3.105900E-02
Daily Drinker-vs-Social Drinker
4.683900E-02
Weekly Drinker-vs-Occasional Drinker
1.204770E-01
Weekly Drinker-vs-Social Drinker
4.980200E-01
Occasional Drinker-vs-Social Drinker
2.380800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.213000E-01
Normal-vs-Grade 2
1.635170E-01
Normal-vs-Grade 3
8.977700E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.979800E-01
Grade 1-vs-Grade 3
9.817600E-01
Grade 1-vs-Grade 4
4.213000E-01
Grade 2-vs-Grade 3
2.653400E-01
Grade 2-vs-Grade 4
1.635170E-01
Grade 3-vs-Grade 4
8.977700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.464200E-01
Normal-vs-NonDiabetic
8.131000E-01
Diabetic-vs-NonDiabetic
3.957200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.229600E-01
Normal-vs-NoPancreatitis
8.003800E-01
Pancreatitis-vs-NoPancreatitis
6.539800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.635200E-01
Normal-vs-N1
7.225800E-01
N0-vs-N1
5.681400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.337000E-01
Normal-vs-TP53-NonMutant
8.767600E-01
TP53-Mutant-vs-TP53-NonMutant
6.967800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
